Endpoint | Ferroquine 400 mg (N = 35) | Ferroquine 400 mg plus artefenomel | ||
---|---|---|---|---|
300 mg (N = 36) | 600 mg (N = 36) | 1000 mg (N = 33) | ||
Parasite clearance rate (1/h) | n = 21 | n = 28 | n = 28 | n = 25 |
Mean (SD) [range] | 0.20 (0.08) [0.10 to 0.39] | 0.36 (0.10) [0.17 to 0.67] | 0.40 (0.12) [0.22 to 0.79] | 0.36 (0.12) [0.07 to 0.60] |
Estimated PRR24, log10 | n = 21 | n = 28 | n = 28 | n = 25 |
Mean (SD) [range] | 2.0 (0.79) [1.00 to 4.09] | 3.76 (1.04) [1.74 to 6.97] | 4.13 (1.25) [2.29 to 8.23] | 3.73 (1.30) [0.70 to 6.30] |
Estimated PRR48, log10 | n = 21 | n = 28 | n = 28 | n = 25 |
Mean (SD) [range] | 4.08 (1.59) [1.99 to 8.18] | 7.52 (2.08) [3.48 to 13.94] | 8.26 (2.50) [4.57 to 16.46] | 7.46 (2.60) [1.41 to 12.60] |
Estimated PRR72, log10 | n = 21 | n = 28 | n = 28 | n = 25 |
Mean (SD) [range] | 6.12 (2.38) [2.99 to 12.27] | 11.28 (3.12) [5.22 to 20.90] | 12.39 (3.75) [6.86 to 24.69] | 11.20 (3.90) [2.11 to 18.90] |
PC50, h | n = 21 | n = 28 | n = 28 | n = 25 |
Mean (SD) [range] | 14.07 (5.60) [6.9 to 25.3] | 7.74 (4.64) [0.4 to 19.9] | 7.78 (3.79) [0.5 to 15.0] | 9.47 (7.98) [0.4 to 33.3] |
TPC50, h | n = 21 | n = 28 | n = 28 | n = 25 |
Geometric mean point estimate (95% CI) | 3.79 (3.29, 4.38) | 1.99 (1.75, 2.25) | 1.81 (1.60, 2.05) | 2.09 (1.84, 2.39) |
PC99, h | n = 21 | n = 28 | n = 28 | n = 25 |
Mean (SD) [range] | 36.92 (9.99) [24.6 to 56.0] | 19.33 (6.11) [6.6 to 33.1] | 18.34 (5.52) [5.6 to 29.4] | 22.95 (17.07) [6.9 to 90.1] |
TPC99, h | n = 21 | n = 28 | n = 28 | n = 25 |
Geometric mean point estimate (95% CI) | 25.21 (21.84, 29.10) | 13.20 (11.66, 14.94) | 12.05 (10.64, 13.65) | 13.91 (12.20, 15.87) |